Maven accelerates tracking and reporting of monkeypox
Company’s Maven® Disease Surveillance & Outbreak Management Platform and epidemiologist team deliver comprehensive support to agencies across 28 jurisdictions, worldwide
The technology platform has been integral in the management of such diseases as COVID-19, Ebola, Zika, measles, tuberculosis, HIV, STDs, influenza, polio and monkeypox
FLORHAM PARK, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions company, has been deeply engaged in disease surveillance for the past 20 years with the development of the Maven® Disease Surveillance & Outbreak Management Platform. Maven has enabled health professionals to quickly scale their response to the public health emergency declared for monkeypox by incorporating the recommendations and requirements of the Centers for Disease Control and Prevention (CDC) into the platform.
In addition to regular updates to Maven’s contact tracing, case, outbreak, and incident management capabilities, Conduent employs seasoned epidemiologists to support public health organizations (PHO) that have been overextended by the sustained response to COVID-19.
Maven is used by public health officials, medical providers, and epidemiologists to facilitate the core mission of public health — prevention, mitigation, and protection — during an outbreak crisis. The U.S. deemed monkeypox a public health emergency in early August, giving PHOs access to additional resources to ramp up education, testing, and contact tracing in their jurisdictions and to improve coordination with local health and community-based organizations. The declaration also requires more robust and immediate data sharing with the CDC, which Maven enables.
“While public health teams remain stretched thin for resources and time as the spread of infectious disease continues, the need to respond rapidly to new and ongoing threats to their communities’ health remains vital. The Maven technology platform, combined with the knowledge of Conduent’s experienced epidemiologists, supports our clients in sustaining heightened vigilance to stop the spread of highly contagious diseases such as monkeypox,” said Lydie Quebe, General Manager of Government Health Solutions at Conduent. “Maven is highly configurable to meet the needs of specific geographies and populations and automates inter-agency information sharing to achieve faster containment of infectious diseases.”
Monkeypox marks the seventh global health emergency declared by the World Health Organization (WHO) over the last 15 years. In each instance, Maven has helped PHO worldwide accomplish the work of protecting public health while securely tracing and monitoring patients infected with, or exposed to, dire communicable diseases. Maven is used across 28 jurisdictions —in the U.S. and internationally— to manage cases of more than 100 reportable conditions. The technology platform has been, and remains, integral in the management of such diseases as COVID-19, Ebola, Zika, measles, tuberculosis, HIV, STDs, influenza, polio and monkeypox.
About Conduent
Conduent delivers mission-critical services and solutions on behalf of businesses and governments – creating exceptional outcomes for its clients and the millions of people who count on them. Through our dedicated people, processes, and technologies, Conduent solutions and services enhance customer experience, increase efficiencies, reduce costs, and improve performance for most Fortune 100 companies and more than 500 government entities. Whether it’s touching three out of every four health insured lives and delivering 45% of SNAP payments in the U.S. or enabling 1.3 billion customer service interactions and empowering 10 million employees through HR services worldwide, Conduent services and solutions interact with millions of people every day and move our clients’ operations forward. Learn more at https://www.conduent.com.
Media Contact:
Sharon Lakes, Conduent, +1-469-750-5403, sharon.lakes2@conduent.com
Investor Relations Contact:
Giles Goodburn, Conduent, +1-203-216-3546, ir@conduent.com
Note: To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives, and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.
Trademarks
Conduent is a trademark of Conduent Incorporated in the United States and/or other countries. Other names may be trademarks of their respective owners.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/50a8b2bc-5b92-46c6-9c8b-637b8d45735f
Related Quotes
Raven, a CNH Industrial brand, actively supports its communities and encourages volunteer efforts whenever possible. This summer, team members have been involved in two volunteering projects that a…
In this article, we will be taking a look at the top 6 long-term stocks to buy according to billionaire Carl Icahn. To skip our detailed analysis of these stocks and Icahn’s investment insights, you can go directly to see the Top 3 Long-Term Stocks to Buy According to Billionaire Carl Icahn. This February, in […]
Here is how Atlas Air Worldwide (AAWW) and Canadian National (CNI) have performed compared to their sector so far this year.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
In Q2, HIV drugs generated more than two-thirds of its total revenue. If you delve further into the details, you'll see that two drugs — Biktarvy and, to a lesser extent, Descovy — appear to be cannibalizing sales of Gilead's other HIV drugs. Gilead is also partnering with Gritstone Bio to evaluate an experimental HIV therapeutic vaccine in an early-stage clinical study.
Clovis (CLVS) files regulatory applications in the United States and Europe seeking label expansion for its sole marketed drug as a first-line maintenance treatment in advanced ovarian cancer.
Treace Medical Concepts Inc (NASDAQ: TMCI) announced an audio poster presentation of the latest interim analysis from the ALIGN3D clinical study following the Lapiplasty Procedure for surgical treatment of hallux valgus (bunions). The data showed: Early return to weight bearing in a walking boot at an average of 8.3 days. A low recurrence rate, defined as loss of radiographic correction, was observed in 1.4% of patients (2 out of 144). An 81% reduction in pain (Visual Analog Scale) was reported
Is Pfizer stock a sell on an expected decline for Covid vaccine sales in the third quarter? Is PFE stock now a sell?
The FDA approval of Sotyktu for psoriasis has ignited and dampened prospects for smaller biotech stocks.
There is little enthusiasm about coming study results for treatments targeting the protein amyloid beta, so there is upside for risk-seeking investors.
U.S. known cases of COVID are continuing to ease and now stand at their lowest level since early May, although the numbers need to be viewed gently, given the number of people testing at home, where the data are not being collected.
The owners of outdoor clothing brand Patagonia just donated the entire company to a nonprofit organization to help combat climate change. Today in health care, Sen. Rand Paul (R-Ky.) and chief White House medical adviser Anthony Fauci got into yet another verbal sparring match, possibly the last one we’ll see before Fauci steps down later this year.…
Alarmed by the nation's low birth rate, the Iranian government is encouraging childbearing and imposing restrictions on abortion and contraception.
Allee and Hendry Gurung only eat potatoes, rice or pasta once every few days
DALLAS, Sept. 13, 2022 — While most parents are good at keeping track of vaccines kids need to stay healthy, many people don’t realize there are immunizations important to keeping adults heart-healthy, as well. The American Heart Association urges all…
OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that it will present its latest innovations and sponsor a scientific program at Transcatheter Cardiovascular Therapeutics (TCT) September 16-19, 2022, held at the Boston Convention and Exhibition Center in Boston, MA. The TCT is an annual scientific symposium of the Cardiovascular Research Found
With many plans and supplements to choose from, signing up for Medicare can be a daunting task. In particular, it can be difficult to determine whether your crucial medications are covered, or if instead you'll be paying a hefty, out-of-pocket price for your prescription drugs. "While Medicare plans do a good job of covering most prescription medications, we commonly see a few medications that aren't covered," says Emily Gang, the leading expert behind The Medicare Coach. Read on to learn about
Photo Illustration by Elizabeth Brockway/The Daily Beast/GettyWhat type of king will Charles III be?This is a question I have been asked many times during recent days. As a scientist, I might be good at establishing facts, but I have to admit I am lousy at reading tea leaves. The best answer I can offer is one based on Charles’ track record in my area of expertise.In his role as Prince of Wales, Charles promoted all sorts of “alternative” nonsense for 40 years. His anti-scientific stance went so
“Getting hit with a baseball bat once is better than getting hit five times,” one expert said.View Entire Post ›
With more than 17 million Americans with NASH, the fatty liver disease has been a prime target for drug developers. But few have been able to show promising clinical trial results.
